Search

Author/Creator Du, Guangying

1. Combinatorial antitumor effects of indoleamine 2, 3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model. (September 2017)

Authors:
Meng, Xiangjing; Du, Guangying; Ye, Liang; Sun, Shanyue; Liu, Qiaofeng; Wang, Hongbo; Wang, Wenyan; Wu, Zimei; Tian, Jingwei
Journal:
International journal of immunopathology and pharmacology
Issue:
Volume 30:Number 3(2017)
Page Start:
215
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis. (13th June 2013)

Authors:
Wang, Hongbo; Yu, Pengfei; Bai, Jing; Zhang, Jianqiao; Kong, Liang; Zhang, Fangxi; Du, Guangying; Pei, Shiqian; Zhang, Lixia; Jiang, Yongtao; Tian, Jingwei; Fu, Fenghua
Other Names:
Sethi Gautam Academic Editor.
Journal:
Evidence-based complementary and alternative medicine
Issue:
Volume 2013(2013)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. PCC0208009 enhances the anti-tumor effects of temozolomide through direct inhibition and transcriptional regulation of indoleamine 2, 3-dioxygenase in glioma models. (11th July 2018)

Authors:
Sun, Shanyue; Du, Guangying; Xue, Jiang; Ma, Jinbo; Ge, Minmin; Wang, Hongbo; Tian, Jingwei
Journal:
International journal of immunopathology and pharmacology
Issue:
Volume 32:Mar./Dec.(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗